1. Home
  2. TENX vs SRFM Comparison

TENX vs SRFM Comparison

Compare TENX & SRFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • SRFM
  • Stock Information
  • Founded
  • TENX 1967
  • SRFM 2011
  • Country
  • TENX United States
  • SRFM United States
  • Employees
  • TENX N/A
  • SRFM N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • SRFM Transportation Services
  • Sector
  • TENX Health Care
  • SRFM Consumer Discretionary
  • Exchange
  • TENX Nasdaq
  • SRFM Nasdaq
  • Market Cap
  • TENX 11.4M
  • SRFM 15.0M
  • IPO Year
  • TENX N/A
  • SRFM 2023
  • Fundamental
  • Price
  • TENX $3.39
  • SRFM $2.29
  • Analyst Decision
  • TENX Strong Buy
  • SRFM Hold
  • Analyst Count
  • TENX 2
  • SRFM 2
  • Target Price
  • TENX $30.00
  • SRFM $2.50
  • AVG Volume (30 Days)
  • TENX 29.1K
  • SRFM 342.2K
  • Earning Date
  • TENX 11-11-2024
  • SRFM 11-12-2024
  • Dividend Yield
  • TENX N/A
  • SRFM N/A
  • EPS Growth
  • TENX N/A
  • SRFM N/A
  • EPS
  • TENX N/A
  • SRFM N/A
  • Revenue
  • TENX N/A
  • SRFM $111,793,000.00
  • Revenue This Year
  • TENX N/A
  • SRFM $104.61
  • Revenue Next Year
  • TENX N/A
  • SRFM $53.30
  • P/E Ratio
  • TENX N/A
  • SRFM N/A
  • Revenue Growth
  • TENX N/A
  • SRFM 392.91
  • 52 Week Low
  • TENX $2.77
  • SRFM $0.90
  • 52 Week High
  • TENX $61.20
  • SRFM $11.83
  • Technical
  • Relative Strength Index (RSI)
  • TENX 42.55
  • SRFM 65.59
  • Support Level
  • TENX $3.28
  • SRFM $1.68
  • Resistance Level
  • TENX $3.54
  • SRFM $2.77
  • Average True Range (ATR)
  • TENX 0.20
  • SRFM 0.28
  • MACD
  • TENX -0.01
  • SRFM 0.12
  • Stochastic Oscillator
  • TENX 26.42
  • SRFM 71.00

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About SRFM Surf Air Mobility Inc.

Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.

Share on Social Networks: